The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK

Interactive Cardiovascular and Thoracic Surgery

Volumn 19, Issue 1, 2014, Pages 41-48

  Borisenko, Oleg ^a   Wylie, Gillian ^b   Payne, John ^c   Bjessmo, Staffan ^a,d   Smith, Jon ^e   Firmin, Richard ^f   Yonan, Nizar ^g  

^a Synergus AB   (Sweden)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e FREEMAN HOSPITAL   (United Kingdom)

^f GLENFIELD HOSPITAL   (United Kingdom)

^g WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Cardiogenic; Costs and cost analysis; Extracorporeal membrane oxygenation; Great Britain; Heart assist devices; Shock

Indexed keywords

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOPULMONARY INSUFFICIENCY; CHILD; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EXTRACORPOREAL LIFE SUPPORT SYSTEM; HEALTH CARE COST; HEART INFARCTION; HUMAN; LIFE SUPPORT EQUIPMENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED KINGDOM; VENTRICULAR ASSIST DEVICE; AGE; COMPARATIVE STUDY; DEVICES; ECONOMICS; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL COST; NATIONAL HEALTH SERVICE; PATHOPHYSIOLOGY; PROSTHESIS; SHOCK, CARDIOGENIC; STATISTICAL MODEL; TIME;

AGE FACTORS; COST SAVINGS; COST-BENEFIT ANALYSIS; EXTRACORPOREAL MEMBRANE OXYGENATION; GREAT BRITAIN; HEART FAILURE; HEART-ASSIST DEVICES; HOSPITAL COSTS; HUMANS; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSTHESIS DESIGN; SHOCK, CARDIOGENIC; STATE MEDICINE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84903829466     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivu078     Document Type: Article

References (24)

1. The National Institute for Health and Care Excellence. Short-Term Circulatory Support with Left Ventricular Assist Devices as a Bridge to Cardiac Transplantation or Recovery. London: The National Institute for Health and Care Excellence, 2006.
2. Annich GM, Lynch WR, MacLaren G, Wilson JM, Bartlett RH (eds). ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, 4th edn. Detroit: Extracorporeal Life Support Organization, 2005.
3. National Specialised Commissioning Team. Service Specification. Ventricular Assist Devices (VADs) for adults as a bridge to heart transplantation or myocardial recovery. London: National Specialised Commissioning Team (NSCT), 2011.
4. National Specialised Commissioning Team. Service Specification. Ventricular Assist Devices (VADs) for children as a bridge to heart transplantation. London: National Specialised Commissioning Team (NSCT), 2011.
5. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357: 885-96. (Pubitemid 47347322)
6. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361: 2241-51.
7. Cove ME, MacLaren G. Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction. Crit Care 2010;14:235.
8. Sayer GT, Baker JN, Parks KA. Heart rescue: the role of mechanical circulatory support in the management of severe refractory cardiogenic shock. Curr Opin Crit Care 2012;18: 409-16.
9. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation 2012; 125: 1809-17.
10. Koerner MM, Jahanyar J. Assist devices for circulatory support in therapy-refractory acute heart failure. Curr Opin Cardiol 2008;23: 399-406. (Pubitemid 351787107)
11. Ziemba EA, John R. Mechanical circulatory support for bridge to decision: which device and when to decide. J Card Surg 2010;25: 425-33.
12. Thomas HL, Dronavalli VB, Parameshwar J, Bonser RS, Banner NR, on behalf of the Steering Group of the UK Cardiothoracic Transplant Audit. Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur J Cardiothorac Surg 2011;40: 1348-54.
13. Nasir A, Bonde P, Graham AN. Ventricular assist device therapy in postcardiotomy cardiogenic shock: historical outcomes and current trends. Interact CardioVasc Thorac Surg 2012;14: 585-7.
14. Hernandez AF, Grab JD, Gammie JS, O'Brien SM, Hammill BG, Rogers JG et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation 2007;116: 606-12. (Pubitemid 47364578)
15. Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M et al. Evaluation of the ventricular assist device programme in the UK. Health Technol Assess 2006;10: 1-119., iii-iv.
16. Peek GJ, Elbourne D, Mugford M, Tiruvoipati R, Wilson A, Allen E et al. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess 2010; 14: 1-46.
17. National Institute for Health and Care Excellence. Medical Technologies Evaluation Programme Methods Guide. London: National Institute for Health and Care Excellence, 2011:32.
18. De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A. Clinical performance with the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant 2006;25: 181-6. (Pubitemid 43156369)
19. John R, Long JW,Massey HT, Griffith BP, Sun BC, Tector AJ et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 2011;141: 932-9.
20. PSSRU. Unit Costs of Health and Social Care 2012. Canterbury, UK: PSSRU, University of Kent, 2012.
21. UK Department of Health. 2010-11 Reference Costs Publication. London: UK Department of Health, 2011.
22. Shuhaiber JH, Jenkins D, Berman M, Parameshwar J, Dhital K, Tsui S et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant 2008;27: 158-64. (Pubitemid 351222639)
23. De Robertis F, Rogers P, Amrani M, Petrou M, Pepper J, Bahrami T et al. Bridge to decision using the Levitronix CentriMag short term ventricular assist device. J Heart Lung Transplant 2008;27: 474-8. (Pubitemid 351602178)
24. Cassidy J, Haynes S, Kirk R, Crossland D, Smith JH, Hamilton L et al. Changing patterns of bridging to heart transplantation in children. J Heart Lung Transplant 2009;28: 249-54.